Jefferies initiates coverage of Mentari Therapeutics at Buy, sets price target at $30

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Jefferies initiated coverage of Mentari Therapeutics at Buy and set a price target of $30.

The price target implies an upside of 87.5% from the Nov 9 close of $16.

Explore more price target data and ratings for Mentari Therapeutics on the , and track all previous and future analyst recommendations in the dedicated News Flow.

Disclaimer
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.